Cabot: Uphill Battle Remains Following Q2 Earnings Release

We last wrote on Cabot Corporation (NYSE: CBT ) in late January of this year when we downgraded the specialty chemicals and performance materials outfit to a 'Hold' rating. Concerning technicals, muted growth rates and poor near-term EPS revisions were primeIndividual investor with a keen interest in deriving income from investment setups. We do this by buying undervalued profitable stocks with strong balance sheets & minimal debt. Furthermore, when the opportunity arises, we like to write calls against our ...